Yili Chuannig Biotechnology Co., Ltd.
Reporting Yili Chuannig Biotechnology Co., Ltd.
Capitalization
IFRS
Annual
LTM | 5 year average | CAGR 5 | |
---|---|---|---|
Капитализация, млрд ¥
|
19.49 | ||
Выручка, млрд ¥
|
4.09 | ||
Чистая прибыль, млрд ¥
|
0.4864 | ||
EV, млрд ¥
|
21.44 | ||
EBITDA, млрд ¥
|
1.32 |
Share
IFRS
Annual
Quarterly
2022 | 2023 | 2024 | LTM | 5 year average | CAGR 5 | |
---|---|---|---|---|---|---|
EPS | 0.0356 | 0.4231 | 0.24 | 0.2293 | 244.74 | |
Цена акции ао | 9.61 | 9.09 | 10.66 | 10.66 | 9.79 | 3.52 |
Efficiency
IFRS
Annual
Quarterly
Coefficients
IFRS
Annual
Quarterly
Dividends
IFRS
Annual
Quarterly
2023 | LTM | Industry average | 5 year average | CAGR 5 | |
---|---|---|---|---|---|
Дивиденд
|
0.093 | 0.09 | 0.0930 | 0.00 | |
Див доход, ао, %
|
1.02 | 1.04 | 1.17 | 1.02 | 0.00 |
Дивиденды / прибыль, %
|
0 | 29.29 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription